iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Aster unveils its 200th drugstore, the stock strikes a 52-week high

7 Sep 2022 , 08:32 AM

After Aster DM announced that it had launched the 200th drugstore in the nation, the company’s shares soared in the morning trade on September 6 and reached a 52-week high of Rs261 on the BSE. According to a press statement from the firm, its retail chain across the nation increased from 1 to 200 in just 18 months.

The 58th Aster Pharmacy in Kerala was inaugurated with the most recent one. Dr. Azad Moopen, the founder-chairman and managing director of Aster DM Healthcare, said that the company is expanding its network of pharmacies as part of its effort to bring omnichannel healthcare delivery to people’s homes. The network already includes hospitals, labs, clinics, and an online consultation platform.

In order to increase its footprint, Aster Pharmacy is now operating in the states of Karnataka, Kerala, and Telangana. Aster Pharmacy CEO Rama Krishna D remarked, “We have been continually noticing an increasing demand from different cities throughout India where consumers usually hunt for trustworthy brands giving fairly priced, simply accessible pharmaceutical items.”

Aster DM reported a weak Q1FY23 performance owing to losses from newly opened hospitals in the Gulf Cooperation Council (GCC) area. However, the business forecasts that by Q4, GCC hospitals’ EBITDA margins would increase to 17—18%. By FY23 and FY24, respectively, the company hopes to achieve operating profit margins of 18 and 20 % in the hospital sector in India.

Over the period of FY22—FEB24E, brokerage company Prabhudas Lilladher anticipates a 9% EBITDA CAGR. With the brownfield expansion and new hospital ramp-up in the GCC, the margin in its India business would progressively increase, it was highlighted. It has a “buy” recommendation on the company with a target price of Rs234 following the release of Q1FY23 financial results.


For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Aster
  • Buzzing Stocks
  • India
  • news
  • Pharma
  • stock market
  • stock to watch
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.